Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to...
Read moreAmgen announced that the New England Journal of Medicine (NEJM) published positive results from the six-month Phase 3 STRIVE study...
Read moreMerck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir),...
Read moreAdvanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization...
Read moreMedian Technologies, The Imaging Phenomics Company® (Paris:ALMDT) announces today that the company has signed a collaboration agreement with the New...
Read moreTakeda Pharmaceutical Company Limited announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a...
Read moreSynpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for...
Read moreMerck KGaA, Darmstadt, Germany, and Pfizer Inc announced that the Phase III JAVELIN Gastric 300 trial did not meet its...
Read moreBiogen and Alkermes plc announced that they have entered into a global license and collaboration agreement to develop and commercialize...
Read moreChronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults. It is due to the growth of...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.